The impact of ePRO presentation during MDTB on clinician discussion of patient fitness and preferences: The INSPIRE intervention pilot.

251 Background: Treatment of pancreatic cancer often entails multiple modalities (e.g., chemotherapy, surgery, radiation) that vary in intensity, timing, and toxicity. While some options are only recommended for ‘fit’ patients regardless of age, formal fitness measures (such as the geriatric assessment [GA]) and patient preferences are seldom utilized during treatment decision-making. Methods: The INtegrating Systematic PatIent-Reported Evaluations into Multi-Disciplinary Tumor Board (INSPIRE-MDTB) intervention involves the presentation of GA and treatment preferences during MDTB discussions of patients with stage I-IV pancreatic adenocarcinoma. This qualitative study inductively analyzed, recorded and transcribed historical (November 2021 - February 2022) and intervention (September 2022 - June 2023) MDTBs using NVivo software. A constant comparative method was used to establish a grounded scheme representative of clinicians’ characterization of patients’ fitness and preferences during decision-making. Results: Recordings of the MDTB of 31 historical and 49 intervention patients with similar gender (52%; 53% female), age (m=68.1; 72.3), race (65%; 59% White), and cancer stage (26%; 22% stage IV) were included. The GA was not utilized in any historical case but was presented in 94% of intervention cases. Compared to historical controls, INSPIRE patients had more frequent discussions of (1) Cancer-Related Factors (e.g. size, location, progression speed; 35% vs. 43%), (2) Individual Risk Factors (e.g. age, comorbidities, tolerance; 90% vs 98%), and (3) Psychosocial Factors (e.g. health literacy, social support, substance use; 19% vs 33%) (Table 1). Preference domains were discussed in 39% of historical and 80% of intervention patients, with notable increases in patients’ concerns regarding physical (0%; 35%) and mental/emotional (0%; 20%) side effects, ability to work (0%; 10%), and the logistics and convenience of treatment (6%; 14%). Conclusions: INSPIRE-enhanced MDTB discussion of patient fitness and preferences represents a promising approach to providing a venue for consistent and systematic presentation and discussion of ePROs. Clinicians’ characterization of patients’ fitness during MDTB. Factors Impacting Fitness Baseline Intervention Cancer Related 11 (35%) 21 (43%) High Risk (size, location) 8 (26%) 16 (33%) Rapid Progression 0 (0%) 3 (6%) Prior or Concurrent Cancer 3 (10%) 3 (6%) Individual Risk Factor 28 (90%) 48 (98%) Age 19 (61%) 26 (53%) Comorbidities 24 (77%) 43 (88%) Weight Loss 11 (35%) 5 (10%) Tolerance 7 (23%) 9 (18%) Psychosocial Factor 6 (19%) 16 (33%) Insurance 2 (6%) 0 (0%) Language Barrier 0 (0%) 1 (2%) Health Literacy 0 (0%) 6 (12%) Social Support 3 (10%) 12 (24%) Substance use 1 (3%) 2 (4%)

Authors

Institutions

Publication Details

Journal
JCO Oncology Practice
Published
2024-09-30
DOI
https://doi.org/10.1200/op.2024.20.10_suppl.251
Primary Topic
Primary Care and Health Outcomes
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The impact of ePRO presentation during MDTB on clinician discussion of patient fitness and preferences: The INSPIRE intervention pilot.

Ryan David Nipp, Nicole L. Henderson, Grant R. Williams, J. Bart Rose et al.
JCO Oncology Practice
Primary Care and Health Outcomes
article

The impact of ePRO presentation during MDTB on clinician discussion of patient fitness and preferences: The INSPIRE intervention pilot.

Ryan David Nipp, Nicole L. Henderson, Grant R. Williams, J. Bart Rose, Garrett Bourne, S. M. Qasim Hussaini, Cameron Pywell, Gabrielle Betty Rocque, Etzael Ortiz Olguin
article en

Abstract

251 Background: Treatment of pancreatic cancer often entails multiple modalities (e.g., chemotherapy, surgery, radiation) that vary in intensity, timing, and toxicity. While some options are only recommended for ‘fit’ patients regardless of age, formal fitness measures (such as the geriatric assessment [GA]) and patient preferences are seldom utilized during treatment decision-making. Methods: The INtegrating Systematic PatIent-Reported Evaluations into Multi-Disciplinary Tumor Board (INSPIRE-MDTB) intervention involves the presentation of GA and treatment preferences during MDTB discussions of patients with stage I-IV pancreatic adenocarcinoma. This qualitative study inductively analyzed, recorded and transcribed historical (November 2021 - February 2022) and intervention (September 2022 - June 2023) MDTBs using NVivo software. A constant comparative method was used to establish a grounded scheme representative of clinicians’ characterization of patients’ fitness and preferences during decision-making. Results: Recordings of the MDTB of 31 historical and 49 intervention patients with similar gender (52%; 53% female), age (m=68.1; 72.3), race (65%; 59% White), and cancer stage (26%; 22% stage IV) were included. The GA was not utilized in any historical case but was presented in 94% of intervention cases. Compared to historical controls, INSPIRE patients had more frequent discussions of (1) Cancer-Related Factors (e.g. size, location, progression speed; 35% vs. 43%), (2) Individual Risk Factors (e.g. age, comorbidities, tolerance; 90% vs 98%), and (3) Psychosocial Factors (e.g. health literacy, social support, substance use; 19% vs 33%) (Table 1). Preference domains were discussed in 39% of historical and 80% of intervention patients, with notable increases in patients’ concerns regarding physical (0%; 35%) and mental/emotional (0%; 20%) side effects, ability to work (0%; 10%), and the logistics and convenience of treatment (6%; 14%). Conclusions: INSPIRE-enhanced MDTB discussion of patient fitness and preferences represents a promising approach to providing a venue for consistent and systematic presentation and discussion of ePROs. Clinicians’ characterization of patients’ fitness during MDTB. Factors Impacting Fitness Baseline Intervention Cancer Related 11 (35%) 21 (43%) High Risk (size, location) 8 (26%) 16 (33%) Rapid Progression 0 (0%) 3 (6%) Prior or Concurrent Cancer 3 (10%) 3 (6%) Individual Risk Factor 28 (90%) 48 (98%) Age 19 (61%) 26 (53%) Comorbidities 24 (77%) 43 (88%) Weight Loss 11 (35%) 5 (10%) Tolerance 7 (23%) 9 (18%) Psychosocial Factor 6 (19%) 16 (33%) Insurance 2 (6%) 0 (0%) Language Barrier 0 (0%) 1 (2%) Health Literacy 0 (0%) 6 (12%) Social Support 3 (10%) 12 (24%) Substance use 1 (3%) 2 (4%)

JCO Oncology PracticeVol. 20(10_suppl)
Oklahoma City University (US), University of Alabama at Birmingham (US), University of Oklahoma (US)
University of Alabama at Birmingham
Openalex Percentile: Top 71%
Primary Care and Health Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.